Ex vivo expansion of natural killer cells for clinical applications

Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

Loredana Ruggeri, Marusca Capanni, Elena Urbani et al. · Science · 2002 · 3.4K citations

Life Sciences, Hematology, Immunology +17

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

Life Sciences, Cell Biology, Immunology +16

FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype

Harry R. Koene, Marion Kleijer, Johan Algra et al. · Blood · 1997 · 782 citations · Full text

Life Sciences, Genetics, Immunology +12

Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.

Jiang-Hong Gong, Guitta Maki, Hans-G. Klingemann · PubMed · 1994 · 729 citations

Life Sciences, Cell Biology, Immunology +10